News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Patent News
PLx Pharma Inc. Announces New U.S. Patents 5/6/2016
LabStyle Innovations Granted Key Patent In Europe Relating To The Dario Diabetes Management Tool 5/5/2016
Rock Creek Pharma Announces Japanese, European And U.S. Patent Developments And Valuation Initiative For Lead Compound 5/5/2016
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of Three Additional Notices Of Allowance With Claims Covering PENNSAID (Diclofenac Sodium Topical Solution) 2% W/W 5/5/2016
ivWatch Announces Issuance Of U.S. Patent For Solving Motion Issues Related To Continuous Peripheral IV Therapy Monitoring 5/4/2016
SpinalCyte, LLC Receives New United States Patent For Spinal Disc Tissue Engineering 5/4/2016
Federal Judge Reopens Gilead (GILD) Case Amid Allegations Former Merck & Co. (MRK) Scientist Lied 5/3/2016
RaNA Therapeutics Awarded First Patent For Transcriptional Activation Platform 5/3/2016
Neuravi Strengthens Patent Portfolio For Novel Stent Retrievers With Newly Issued U.S. And European Patents 5/3/2016
RXi Pharma (RXII) Secures European Patent For Novel RNAi Platform 5/2/2016
Cynata Announces Japanese Patent Office Decision To Grant Patent For Cymerus MSC technology 5/2/2016
AVEO Oncology (AVEO) Announces Filing Of Provisional Patent Applications For AV-353, A Notch 3-Specific Inhibitor Antibody For PAH 5/2/2016
Prima Biomed (PRR.AX) Release: Japanese Patent Grants For IMP321 In Cancer 5/2/2016
U.S. Patent Office Rejects Ethicon (JNJ)’s Petition For Inter Partes Review Of Endoevolution’s Patent 5/2/2016
Google (GOOG)'s Verily Patents Device that Gets Injected Into the Eyeball to Improve Vision 4/29/2016
Spherix (SPEX) Files Complaint For Patent Infringement Against Level 3 Communications, TW Telecom, And 4/28/2016
Colibri Heart Valve, LLC Receives European Patent For A Method Of Making A Pre-Packaged, Sterilized Dry Heart Valve, Pre-Mounted On A Delivery Catheter 4/27/2016
Ceres, Inc. Awarded Two U.S. Patents for Innovative Crop Traits 4/26/2016
Why Patents Are The Lifeblood Of Biotech Companies 4/26/2016
Pinnacle Spine Group Granted Chinese Patent For Innovative Spinal Fusion Technology 4/26/2016
SpinalCyte, LLC Receives New Canadian Patent For Spinal Disc Tissue Engineering 4/25/2016
Creative Medical Health Files Patent On Stem Cell Therapy For Zika Virus Neurological Effects 4/25/2016
Horizon Pharma (HZNP) Announces Settlement Of PENNSAID (Diclofenac Sodium Topical Solution) 2% W/W Patent Litigation With Amneal 4/25/2016
Arch Therapeutics Receives Notice Of Allowance For Patent Covering Systemic Applications For Self-Assembling Peptides 4/25/2016
Illumina (ILMN) Files Patent Infringement Suit In Switzerland Against Genoma SA For Infringement Of NIPT Patents 4/22/2016
Pharmazz Strengthens Its Patent Portfolio With Notice Of Issuance For PMZ-2123 (BQ123) In The Treatment Of Diabetic Ketoacidosis 4/22/2016
Leading Biosciences Announces Issuance Of U.S. Patent For Lead Clinical Asset LB1148 4/21/2016
Swedish Orphan Biovitrum Release: European Patent Granted On New Formulation Of Kineret (Anakinra) 4/21/2016
Creative Medical Technologies, Inc. Announces Filing Of Female Sexual Dysfunction Patent 4/20/2016
RXi Pharma (RXII) Fortifies Its Novel RNAi Patent Portfolio With Notice Of Allowance For Lead Clinical Candidate RXI-109 4/19/2016
Propanc Files Two More Patents Citing New Compositions Of Proenzymes For Cancer Treatment 4/19/2016
ALSP, Inc. Obtains Patent 4/19/2016
Faron Pharmaceuticals Ltd. Files Two New Patents To Strengthen Protection For Novel Immunotherapy Drug Candidate, Clevegen 4/19/2016
ISA Pharmaceuticals Obtains Broad Patent Protection In The US For Proprietary AMPLIVANT Platform And Compounds 4/19/2016
Mystic Pharmaceuticals Receives Us Patent For Novel Nose To Brain Delivery Of Therapeutics To Treat Neurodegenerative Disorders 4/19/2016
BioCellChallenge SAS Extends Technology Patent For Antibody Internalization To North America 4/19/2016
Cytori Therapeutics (CYTX) Strengthens Global Patent Portfolio 4/18/2016
ResMed (RMD) Files Patent Infringement Action Against BMC And 3B CPAP Devices 4/15/2016
Soligenix (SNGX) Announces Issuance Of New Patents For Dusquetide 4/14/2016
Therabron Receives Notice Of Allowance For New Patent Supporting The Recombinant CC10 Technology Platform 4/13/2016
More Decisions In Favor Of BMC Medical Co., Ltd. In Its Ongoing Patent War Against ResMed (RMD) 4/13/2016
Oramed (ORMP) Receives Patent Term Adjustment Extending The Term Of Its U.S. Patent 4/12/2016
Kadimastem Is Granted A Patent In Japan For Diabetes Treatment 4/12/2016
Arch Therapeutics Announces Notice Of Allowance For Method Of Use Patent Covering Uses Of Self-Assembling Peptides 4/11/2016
Patent Awarded To 4WEB Medical For Novel Programmable Truss Implant Technology 4/8/2016
Will Yale University's Department of Psychiatry Defend The Profession's Teachings On Eating Disorders To Support A Timely "Final Resolution" To "The Patent '813 Story, Part II" -- Or Will The Story Continue In Its Relative Public Obscurity While Its Behind-The-Scenes Drama Profoundly Intensifies? 4/7/2016
Cold Spring Harbor Laboratory Reports That The U.S. Patent Office Denies All 4 Petitions Filed By Benitec (BLT.AX) Against CSHL’s shRNA Patents 4/7/2016
Intec Pharma Ltd. Expands Intellectual Property For AP-CDLD With Patent In South Korea 4/6/2016
Zecotek Photonics Inc. Receives First Patent For New Advanced Formulation Of Its Worldwide Patented LFS Scintillation Crystals 4/6/2016
RegeneRx Biopharmaceuticals, Inc. (RGRX) To Receive EU Patent For Use Of Tß4 In Preventing And Treating Damage Associated With Reperfusion Injury 4/6/2016
Arch Therapeutics Announces Notice Of Allowance For Composition-of-Matter Patent Covering Self-Assembling Peptides 4/6/2016
MorphoSys AG Sues Janssen Biotech Inc. (JNJ) And Genmab A/S (GEN.CO) For Patent Infringement 4/4/2016
Mabion Release: Biosimilar Rituximab -- Many Have Started -- Only A Few Will Succeed 4/1/2016
GlaxoSmithKline (GSK) Lays Out Patent Plan to Help Poor Countries 3/31/2016
RXi Pharma (RXII) Strengthens Intellectual Property Portfolio For Dermal Indications 3/31/2016
Endonovo Receives USPTO Notice Of Allowance For Patent Covering Production Of Biomolecules From Adult Stem Cells 3/31/2016
Oramed (ORMP) Patent Granted In India For Oral Administration Of Proteins 3/29/2016
Shire (SHPG) Wins Patent Trial Against Watson Pharmaceuticals, Inc. (WPI) Concerning LIALDA 3/29/2016
Poxel Has Been Granted U.S. Composition Of Matter Patent For Direct AMPK Activator PXL770 For The Potential Treatment Of Type 2 Diabetes And Related Disorders 3/29/2016
Dipexium Pharmaceuticals (DPRX) Announces Issuance Of Locilex Patent In Japan 3/28/2016
Gilead (GILD) Ordered to Pay Merck & Co. (MRK) $200 Million in Damages Over Hep C Patent Dispute 3/25/2016
More Bad Luck for Gilead (GILD) as Merck & Co. (MRK) Wins Victory in Hep C Patent Dispute 3/24/2016
IRIDEX (IRIX) Gains Patent Approvals Covering TxCell-Guided MicroPulse Laser Therapy; Predictably Enables Faster, Durable Treatments For Glaucoma And Retinal Diseases 3/23/2016
Graematter Granted Additional U.S. Patent For Open Data 3/23/2016
Sequenom (SQNM) Files Petition With The Supreme Court Of The United States Requesting Review Of Decision On '540 Patent 3/22/2016
A1M Pharma Finalizes Drug Candidate For Treating Pre-Eclampsia And Files For Substance Patent 3/22/2016
Body Labs Secures Exclusive U.S. Patents And Licenses For 3D Body Modeling Technologies 3/21/2016
BioNet-Asia Announces The Formation Of Its Scientific Advisory Board 3/21/2016
Acorda (ACOR) Wins Federal Circuit Appeal Allowing AMPYRA Patent Litigation To Continue In Delaware District Court 3/21/2016
Cantargia Receives Patent Approval In Japan And Mexico 3/21/2016
Mawi DNA Technologies Announces Patent For Sample Recovery And Collection Device 3/21/2016
Amgen (AMGN) Wins Trial Against Regeneron (REGN) and Sanofi (SNY) for Cholesterol Drug Patents, Appeal Likely 3/18/2016
Allergan (AGN) Confirms Generic Abraxane Patent Challenge 3/17/2016
MiNA Granted U.S. Patent Covering Small Activating RNAs Targeting the CEBPA Gene 3/17/2016
Caris Life Sciences Announces Allowances Of Two New Patents For Its Proprietary Offering Caris Molecular Intelligence 3/16/2016
Arcturus Therapeutics Receives Intent To Grant Notice From The European Patent Office For Their Unlocked Nucleomonomer Agent (UNA) Technology 3/16/2016
BioInvent (BOVNF) Is Granted A Patent In Europe For The Immune-Oncology Antibody BI-505 3/16/2016
ERYtech Pharma Receives USPTO Notice Of Allowance For Patent Covering ERYCAPS Immunotherapy Technology 3/16/2016
Sunshine Biopharma, Inc. Eliminates The Debt Obligations Associated With The Recently Acquired Patents For Its Adva-27a Anticancer Compound 3/16/2016
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAVICTI (Glycerol Phenylbutyrate) Oral Liquid 3/16/2016
Ortek's Electronic Device To Detect The Earliest Signs Of Dental Cavities Awarded A U.S. Patent 3/16/2016
Interview with GlaxoSmithKline (GSK)'s Possible Successor to CEO Andrew Witty 3/15/2016
Axsome Receives New U.S. Patent Covering AXS-02 for the Treatment of Complex Regional Pain Syndrome 3/15/2016
DECN Subsidiaries Sue Johnson & Johnson (JNJ) And Several Divisions For Patent Infringement 3/15/2016
Bioo Scientific Corporation Granted Patent For Small RNA Sequencing Technology 3/15/2016
Acorda (ACOR) Announces Patent Trials And Appeal Board (PTAB) Institutes IPRs Of AMPYRA Patents 3/14/2016
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 3/14/2016
USPTO Declines To Institute All Inter Partes Review Petitions Filed By CFAD Of INSYS U.S. Patents Directed To SUBSYS (Fentanyl Sublingual Spray) 3/10/2016
Invion Limited Release: Notice Of Allowance Received From PR China For Use Of Oral Nadolol In Smoking Cessation 3/10/2016
LabStyle Innovations Granted U.S. Patent Expanding IP For Fluids Testing Into Industrial Applications Via Mobile Devices And Apps 3/9/2016
Merus Announces Issuance Of Three U.S. Patents Strengthening Its Biclonics Technology Platform For The Discovery And Manufacturing Of Human Bispecific Antibodies 3/9/2016
Katama Pharmaceuticals Receives A Notice Of Allowance Of A Composition Of Matter Patent For Tolperisone 3/9/2016
Akebia (AKBA) Prevails In European Patent Dispute And Preserves Access To Key Market For Vadadustat 3/9/2016
Angle European Patent Grant For Parsortix 3/9/2016
Puritan Medical Products Company, LLC Awarded Second US Patent for PurFlock Ultra Flocked Swabs 3/9/2016
Inotek Pharmaceuticals Corporation (ITEK) Strengthens Patent Estate For Lead Product Candidate Trabodenoson 3/9/2016
SciFluor Life Sciences, LLC Awarded Second U.S. Patent For Integrin avß3 (SF0166) Inhibitors Designed For The Topical Treatment Of Retinal Disease 3/9/2016
Spherix (SPEX) Announces Collaborative Agreement To Monetize Patents 3/8/2016
Key TxCell Patent To Be Granted In Japan For Its Lead Product Ovasave 3/8/2016
Accusations of Errors and Deception Fly in CRISPR Patent Fight 3/8/2016
Amgen (AMGN) Aggressively Challenges Pfizer (PFE) and Novartis AG (NVS) Biosimilar Drugs 3/7/2016
Fotona Obtains Patent For Its FracTat Method For Lightening Or Eradicating Pigments In Human Skin 3/7/2016
Puritan Medical Products Company, LLC Solidifies Its Position In Flocked Swab Technology With New U.S. Patent 3/7/2016
Debiopharm Has Won Its Patent Infringement Suit For Elplat Against Nippon Kayaku Co., Ltd. 3/4/2016
European Patent Grant Further Strengthens c-LEcta’s Core Technologies 3/4/2016
Bio-AMD: MIDS Patent Grant In People's Republic Of China 3/3/2016
New Patent Issued To Cantex Pharmaceuticals For Its Lead Product Candidate In The Treatment Of Thrombocytopenia And Neutropenia 3/2/2016
Trianni Announces Issuance Of Russian Federation Patent 3/2/2016
XTL Biopharma (XTLB) Expands Global IP Portfolio With Issued Patent In Hungary For Lupus Drug Hcdr1 3/2/2016
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID(R) (Diclofenac Sodium Topical Solution) 2% W/W 3/2/2016
Synthetic Biologics (SYN) Announces Further U.S. Patent Successes Covering SYN-004 Intended For The Prevention Of C. Difficile Infection And Antibiotic-Associated Diarrhea 3/1/2016
Celsion (CLSN) Announces Issuance Of Key U.S. Patent Covering Its Novel TheraSilence RNA Program 3/1/2016
Intrommune Therapeutics Announces Issuance Of U.S. Patent Covering Oral Mucosal Immunotherapy For Food Allergy 3/1/2016
Provectus Awarded Patent Extending Protection Of The PV-10 Manufacturing Process 3/1/2016
STC-Stem Cell Treatment & Research Institute Registers Local Patent For Method To Mass Produce Pluripotent Stem Cells Without Side Effects 2/29/2016
Amarantus BioSciences Receives Notices Of Allowance From European Patent Office For MANF And CDNF In The Treatment Of Retinal Disorders 2/29/2016
Creative Medical Health Announces Creation Of Angiostem Inc. Subsidiary To Commercialize Issued Cardiovascular Stem Cell Patent 2/29/2016
Allovate Announces Issuance Of U.S. Patent Covering Novel Oral Mucosal Immunotherapy Platform 2/29/2016
Sancilio & Company Announces U.S. PTO Allowance Of Patent Claims 2/25/2016
Oncoceutics Release: U.S. Patent Issued For ONC201 Composition Of Matter 2/25/2016
Aridis Pharmaceuticals Expands Patent Portfolio For Several Fully Human Monoclonal Antibodies Against Infectious Disease Targets 2/24/2016
Stryker-Zimmer (ZMH) Case Has Supremes Eying Stiffer Patent Penalties 2/24/2016
RedHill Biopharma (RDHL) Announces Notice Of Allowance For U.S. Patent Covering RIZAPORT For Migraines 2/24/2016
Symplmed Announces FDA Orange Book Listing For Two Prestalia Patents 2/24/2016
Zero Gravity Solutions Issued Patent For Its Commercial Product For Agriculture, BAM-FX™, By The United States Patent And Trademark Office 2/24/2016
Oxis Biotech Gains Key Patent Ruling For Its Cancer Drug, OXS-1550 2/23/2016
Eagle Pharma (EGRX) Receives Sixth Patent For Bendamustine 2/23/2016
MediGene AG (MDGEF.PK) Strengthens Its DC Platform With Patent For Treatment Of Stem Cell Or Bone-Marrow Transplanted Patients 2/23/2016
Echo Therapeutics (ECTE) Announces New Patents for Non-Invasive Sensing Technology 2/22/2016
Lipogen Ltd. Targets PMS/PMDD Relief, Naturally 2/22/2016
Proa Medical Receives China And Russia Patent Grants For Its First Device For Women’s Health 2/22/2016
Novogen Limited (NVGN) Patent Covering Cantrixil And Trilexium Has Proceeded To Grant 2/19/2016
Oragenics, Inc. (OGEN) Receives New Patent For Improved Replacement Therapy For Dental Caries 2/19/2016
TapImmune (TPIV) Receives Notice Of Allowance On U.S. Patent Claims For PolyStart - Next-Generation T-Cell Vaccine 2/18/2016
IntelGenx Corp. Announces USPTO Has Granted Patent Protecting RIZAPORT Oral Film For Migraines 2/18/2016
Synthetic Biologics (SYN) Announces The Allowance Of Key U.S. Patent Covering SYN-010 Intended For The Novel Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C) 2/17/2016
NLS Pharma Acquires A Portfolio Of Strategic Patents 2/17/2016
UK Court Rules Against Eli Lilly (LLY) In Alimta Vitamin Regimen Patent Lawsuit 2/12/2016
Ocugen, Inc. Expands Ophthalmology Portfolio 2/12/2016
Integral Molecular, Inc. Expands Intellectual Property Landscape With International Patents Protecting Key Lipoparticle Technology 2/11/2016
XTL Biopharma (XTLB)' Lupus Drug hCDR1 Granted Patent For Pharmaceutical Composition & Manufacturing Processes 2/10/2016
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For Novel Lipid-Crystal Nano-Particle Cochleate Formulation Technology 2/10/2016
RedHill Biopharma (RDHL) Receives Notice Of Allowance Of Fifth U.S. Patent Covering RHB-104 Phase III Crohn's Disease Program 2/10/2016
Telephus Medical Announces Australian Patent For Therapeutic Antibodies To Treat Staphylococcus Aureus Infections 2/10/2016
Japanese Patent Office Issues Decision To Grant Patent For USMI’s Canady Hybrid Plasma Technology 2/10/2016
Applied BioCode, Inc. Awarded Digital Barcode Patent For Identifying Multiplexed Biomarkers Or Pathogens 2/10/2016
IntelGenx Corp. Files Loxapine Oral Film Patent For Schizophrenia 2/10/2016
HemaFLO Therapeutics Announces Issuance Of Key Patent For NephroFlow 2/8/2016
VLP Therapeutics Announces Issuance Of U.S. Composition Of Matter Patent For I-A Virus Like Particle Platform Technology 2/8/2016
Palatin Tech (PTN) Strengthens Intellectual Property Surrounding Use Of Bremelanotide For Female Sexual Dysfunction 2/8/2016
BMC Medical Co., Ltd Wins Patent Infringement Litigation Against ResMed (RMD) 2/8/2016
Therapeutics Solutions Announces The Licensing Of Exosome Technology To MolecuVax, Inc. 2/8/2016
Zealand Pharma  (ZEAL.CO) Clarifies Its Role In U.S. Patent Litigation Relating To Lixisenatide And Confirms Its Confidence In A Strong Patent Status For The Product 2/5/2016
Almac Discovery Secures Patent Protection For Novel Allosteric Akt inhibitor (ALM301) 2/4/2016
CorMatrix Cardiovascular Secures Forty-one (41) U.S. Patents In 2015 Including Additional Prosthetic Heart Valve Patents 2/4/2016
Regen BioPharma Files Patent Application Covering Innate Immune Activating NR2F6 Silenced CAR-T Cell For Solid Tumors 2/3/2016
Amarantus BioSciences Receives Dual Notices Of Allowance From European Patent Office For Engineered Skin Substitute (ESS) 2/3/2016
Trianni Announces Issuance Of Patent In Australia 2/3/2016
Cantargia Patent Granted In Australia 2/3/2016
Kymab Succeeds In Revoking Regeneron (REGN)’s UK VelocImmune Patents 2/2/2016
Reflow Awarded New U.S. Patent For Innovative Wingman Crossing Catheter Technology 2/2/2016
Dipexium Pharmaceuticals (DPRX) Announces Issuance Of Locilex Patents In Australia And New Zealand 2/1/2016
Amarantus BioSciences Announces Issuance Of Chinese Patent Covering Use Of MANF For The Treatment Of Parkinson's Disease 1/29/2016
Prima Biomed (PRR.AX) Release: U.S. Patent Grants For IMP731 Antibody 1/28/2016
BiondVax Pharmaceuticals's Universal Flu Vaccine Receives Additional US Patent 1/27/2016
Axsome Announces Issuance Of U.S. Patent Covering AXS-02 For The Treatment Of Bone Marrow Lesions Of The Knee 1/27/2016
Thetis Awarded Key Patent On HEALER Technology 1/27/2016
Telephus Medical Announces Issuance of Canada Patent for Anti-MRSA Antibodies 1/27/2016
Kaleo Announces The Award Of Its 100th Patent 1/26/2016
Premier Biomedical Files Provisional Patent Application On Second Drug To Treat Fibromyalgia, Neuropathic Pain, MS Symptoms, And Alcohol And Chemical Addiction 1/26/2016
AEterna Zentaris (AEZS) Files International Patent Application For Novel Method Of Manufacturing Zoptrex 1/26/2016
Rosetta Genomics Ltd. (ROSG) Granted U.S. Patent Allowance For Use Of Gene Expression Signature For Classification Of Kidney Tumors 1/25/2016
OncBioMune Receives Notice Of Allowance For Patent Covering New Targeted Cancer Treatments 1/22/2016
Kadimastem Receives Patent Allowance In The United States For Its Technology In The Field Of Diabetes Treatment 1/21/2016
Sample6 Awarded New Patent For Phage Engineering Technology 1/21/2016
Dramatic Turn In Story Of Invalidated '813 Patent For Treating Binge Eating Disorder As Owner Lucerne Biosciences Provides Patent Board Profile Of Itself And Its High 40-75% Misrepresentation Rate 1/21/2016
Agienic Release: Three Key Patents Issued To Antimicrobial Company 1/21/2016
U.S. Patent & Trademark Office Issues Notice Of Allowance For Can-Fite BioPharma (CFBI)'s Sexual Dysfunction Drug CF602 1/19/2016
Summit Therapeutics Granted Key European Patent For Novel Antibiotic Ridinilazole For Treatment Of C. Difficile Infection 1/19/2016
Swedish Orphan Biovitrum's Orfadin Oral Suspension Granted European Patent 1/19/2016
EastGate Biotech Receives Notice Of Publication From The US Patent And Trademark Office For Two Patents For The Company's Proprietary Intraoral Lorazepam Spray 1/19/2016
Telephus Medical Announces Issuance Of Japanese Patent For Anti-MRSA Antibodies 1/18/2016
Amgen (AMGN) Cringes as Officials Reject Petition Against AbbVie (ABBV) Patents 1/18/2016
Lucerne Biosciences Completes Sourcing Investigation Into Shire (SHPG)'s IPR That Led To The Invalidation Of The '813 Patent 1/15/2016
Alitair Pharmaceuticals Announces Issuance Of Patent Covering Its Prescription Drug Overdose Reduction Technology, ODR 1/15/2016
Mach 7 Technologies Awarded U.S. Patent For Medical Image Capture With A Mobile Device 1/13/2016
Lucerne Biosciences Completes Sourcing Investigation Into Shire (SHPG)'s IPR That Led To The Invalidation Of The '813 Patent; Begins Accelerated Multi-Party Public Expansion Phase Of Its Counter-Intelligence Technology 1/12/2016
Halo-Bio RNAi Therapeutics Issued U.S. Patent For New Class Of RNAi Trigger 1/12/2016
Entac Medical Announces U.S. Patent Issuance For Platform Technology To Predict Gastrointestinal Impairment In Surgical Patients 1/12/2016
Key Patents Granted For Probiodrug AG’s pGlu-Abeta Targeting Monoclonal Antibody Program For The Treatment Of Alzheimer’s Disease 1/11/2016
SpinalCyte, LLC Receives New Chinese Patent For Spinal Disc Tissue Engineering 1/8/2016
Gen9 Awarded Four U.S. Patents For Innovation In Synthetic Biology 1/8/2016
BioMarker Strategies Announces Issuance Of Key Patents In The United States, Europe, Australia And Hong Kong 1/7/2016
Enzo Biochem (ENZ) Reaches $9 Million Patent Infringement Settlement With Agilent Technologies Inc. (A) 1/6/2016
Valencell Files Patent Infringement Suit Against Apple (AAPL) And Fitbit, Inc. 1/5/2016
Orthocell’s ‘Cell Factory’ Granted Patent in U.S. 1/5/2016
Helius Medical Technologies Announces Allowances Of 10 New Patents 1/5/2016
VolitionRX Granted Its Third U.S. Patent 1/4/2016
Cantargia Patent Granted By The European Patent Office 1/4/2016
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAVICTI (Glycerol Phenylbutyrate) Oral Liquid 1/4/2016



//-->